Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Investigational drug gains upper hand over placebo in reducing CDI recurrence rates
20 May 2022
bởiAudrey Abella
SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.
20 May 2022

Stroke while on anticoagulant therapy predicts recurrence, bleeding risks
20 May 2022
Patients who have had a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are likely to experience a recurrent ischaemic stroke episode and bleeding, according to data from the RENO-EXTEND Study.
20 May 2022

Sustained benefits with ocrelizumab in relapsing-remitting MS
19 May 2022
bởiRoshini Claire Anthony
Patients with relapsing-remitting multiple sclerosis (RRMS) who have suboptimal response to disease-modifying therapies (DMTs) experienced low disease activity after switching to ocrelizumab, according to interim results of the LIBERTO study.
19 May 2022






